Loading…
Claritev Corporation is projected to rise to $37.82 by 2027, a +21% move from its current price of $31.24. CTEV is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $29.79 | $31.28 | $32.85 | +0.14% |
| Jul 13 | $29.23 | $31.33 | $33.57 | +0.28% |
| Jul 14 | $28.82 | $31.37 | $34.15 | +0.42% |
| Jul 15 | $28.49 | $31.42 | $34.64 | +0.57% |
| Jul 16 | $28.20 | $31.46 | $35.10 | +0.71% |
| Jul 17 | $27.95 | $31.51 | $35.51 | +0.85% |
| Jul 18 | $27.72 | $31.55 | $35.91 | +0.99% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $27.72 | $31.55 | $35.91 | +0.99% |
| Week 2 | $26.53 | $31.86 | $38.26 | +1.99% |
| Week 3 | $25.72 | $32.18 | $40.26 | +3.00% |
| Week 4 | $25.09 | $32.50 | $42.10 | +4.03% |
| Week 5 | $24.57 | $32.82 | $43.83 | +5.06% |
| Week 6 | $24.14 | $33.15 | $45.51 | +6.10% |
| Week 7 | $23.77 | $33.47 | $47.14 | +7.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Claritev Corporation provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consisting of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services.
It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process.
The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.
Claritev Corporation (CTEV) operates in the Healthcare sector as a provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions. The stock trades with a current price of $31.62 and a market capitalization of $539.05M, and is ranked 3004 by size.
The near-term price picture sits within a framework of mixed-to-bullish technical signals. The stock’s 50-day simple moving average is $26.96, while the 200-day simple moving average is $33.71, and the price currently rests near $31.62. The 30-day range spans from $22.45 to $44.54, with a defined support at $21.67 and resistance at $34.72.
Annualized volatility stands at 100%.
Forecasts project substantial upside across the long horizon, with the average price rising from $31.62 in 2026 to $774.52 by 2050, and maximums climbing to $1,781.39 in 2050. The multi-year view shows a progression from neutral in 2026 to bullish momentum through 2050, yielding a cumulative upside indicated by growing average prices and high max values.
A major floor 55.6% below — a decisive break under it would weaken the trend.
The nearest floor, 21.4% below — buyers have tended to step in here.
The nearest ceiling, 11.1% above — a clean break opens room to run.
A major ceiling 29.1% above — clearing it would confirm fresh momentum.
Key CTEV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CTEV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $32.19 | Sell | $32.09 | Sell |
| MA 10 | $32.71 | Sell | $32.11 | Sell |
| MA 20 | $31.71 | Sell | $31.17 | Buy |
| MA 50 | $27.45 | Buy | $28.18 | Buy |
| MA 100 | $22.75 | Buy | $27.50 | Buy |
| MA 200 | $33.39 | Sell | $30.00 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.83 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -22.43 | Neutral |
| Williams %R (14) | -55.41 | Info |
| MACD (12,26,9) | -0.34 | Sell |
| ROC (12) | 3.93 | Buy |
| Bollinger %B (20,2) | 0.43 | Neutral |
| Stochastic %K (14) | 44.59 | Neutral |
| TRIX (15) | 0.99 | Buy |
| Awesome (5,34) | 2.95 | Buy |
| Ultimate (7,14,28) | 41.04 | Neutral |
| Momentum (10) | -3.48 | Sell |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 31.79 | Sell |
| ADX (14) | 18.11 | Neutral |
| ATR (14) | 1.21 | Info |
The 30-day technical picture shows the stock trading within a broad range, with the 30-day low at $22.45 and the high at $44.54. The RSI14 sits at 60, suggesting ongoing bullish potential without overbought conditions.
Traders should note the moving-average context: the SMA50 is $26.96 and the SMA200 is $33.71, indicating near-term price pressure around the mid-to-upper $30s. Support sits at $21.67 and resistance at $34.72, framing a window where price action could test the resistance level near the end of the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.47 | $31.24 | $52.29 | 0% | Neutral | |
| $27.90 | $37.82 | $55.32 | +21% | Bullish | |
| $32.66 | $46.77 | $72.60 | +50% | Bullish | |
| $40.10 | $60.15 | $97.73 | +93% | Bullish | |
| $47.55 | $74.38 | $125.50 | +138% | Bullish | |
| $66.56 | $108.25 | $188.70 | +247% | Bullish | |
| $71.07 | $119.96 | $215.25 | +284% | Bullish | |
| $71.19 | $124.50 | $229.26 | +299% | Bullish | |
| $80.87 | $146.36 | $275.98 | +369% | Bullish | |
| $72.73 | $136.11 | $262.32 | +336% | Bullish | |
| $129.79 | $285.20 | $601.30 | +813% | Bullish | |
| $343.86 | $764.13 | $1,757.50 | +23.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $13.47 | $31.24 | $40.08 | +0.00% |
| August 2026 | $29.30 | $35.34 | $44.31 | +13.13% |
| September 2026 | $29.08 | $35.53 | $45.40 | +0.52% |
| October 2026 | $29.39 | $36.31 | $47.14 | +2.20% |
| November 2026 | $31.13 | $38.82 | $51.08 | +6.93% |
| December 2026 | $31.21 | $39.26 | $52.29 | +1.14% |
Click any year to see its month-by-month CTEV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CTEV is projected to trade between $13.47 and $52.29, averaging $31.24 — a potential gain of 0% from today's $31.24. A consolidation phase looks the most probable path here.
Claritev Corporation's 2027 outlook centres on $37.82, within a $27.90 to $55.32 range. That is up +21% on the projected 2026 average. That marks a +21% change versus current levels. Momentum favours further upside here.
By 2028, CTEV could reach as high as $72.60, with a base case around $46.77 and support toward $32.66 — roughly +50% from $31.24. Buyers look set to stay in control over this stretch.
Expect CTEV to range from $40.10 to $97.73 through 2029. The $60.15 average target implies a +93% move from current prices. That is up +29% on the projected 2028 average. Momentum favours further upside here.
The CTEV price prediction for 2030 points to an average of $74.38 (low $47.55, high $125.50) — a potential gain of +138% on today's $31.24. Buyers look set to stay in control over this stretch.
In 2031, CTEV is projected to trade between $66.56 and $188.70, averaging $108.25 — a potential gain of +247% from today's $31.24. That is up +46% on the projected 2030 average. Momentum favours further upside here.
Claritev Corporation's 2032 outlook centres on $119.96, within a $71.07 to $215.25 range. That is up +11% on the projected 2031 average. That marks a +284% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CTEV could reach as high as $229.26, with a base case around $124.50 and support toward $71.19 — roughly +299% from $31.24. Momentum favours further upside here.
Expect CTEV to range from $80.87 to $275.98 through 2034. The $146.36 average target implies a +369% move from current prices. That is up +18% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CTEV price prediction for 2035 points to an average of $136.11 (low $72.73, high $262.32) — a potential gain of +336% on today's $31.24. Momentum favours further upside here.
In 2040, CTEV is projected to trade between $129.79 and $601.30, averaging $285.20 — a potential gain of +813% from today's $31.24. That is up +110% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Claritev Corporation's 2050 outlook centres on $764.13, within a $343.86 to $1,757.50 range. That is up +168% on the projected 2040 average. That marks a +23.5x change versus current levels. Momentum favours further upside here.
Investing $1,000 in CTEV today (≈ 32.010243 CTEV) could be worth
$24,460.07
+$23,460.07 (+2346%) by 2050 · US Dollar
Based on the average projected CTEV price of $764.13 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CTEVwould be worth at today's price.
$1,000 invested in CTEV on Jul 10, 2025 (≈ 20.99958 CTEV) would be worth
$656.03
-$343.97 (-34.4%) today · 0.66× · US Dollar
Based on a CTEV entry price of $47.62 vs. today's $31.24.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $32.64 | $957.11 | -4.3% |
| 1 month ago | $29.74 | $1,050.44 | +5.0% |
| 3 months ago | $16.24 | $1,923.65 | +92.4% |
| 6 months ago | $31.96 | $977.47 | -2.3% |
| 1 year ago | $47.62 | $656.03 | -34.4% |
| All time (5.0y) ago | $287.2 | $108.77 | -89.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CTEV forecast.
Our base-case forecast reaches $62.00 around 2030.
Implied market cap at $62.00: $1.06B
The multi-year forecast shows meaningful upside across the horizon. For 2026, the min, avg, and max are $13.47, $31.62, and $53.55 respectively, with an ROI of 0% and a neutral sentiment. By 2027, the forecast envisions an average of $37.89 and a max of $56.17, with a 19.8% ROI and neutral sentiment.
From 2028 onward, sentiment is bullish, with 2028 an average of $47.18 and a max of $74.43 (49.2% ROI); 2029 an average of $60.46 and a max of $100.02 (91.2% ROI).
In 2030, the average price is projected at $75.05 with a max of $129.13 and a 137.3% ROI, continuing bullish sentiment. The path extends through 2031–2035 with rising averages and strong upside, then accelerates dramatically toward 2040 (average $290.03, max $628.71, ROI 817.2%) and culminates in 2050 (average $774.52, max $1,781.39, ROI 2349.4%). The outlook carries bullish momentum across the long horizon but remains subject to market variability and is not a guarantee.
Tap a question to reveal the answer.
The forecast shows an average price of $75.05 with a max of $129.13 and a ROI of 137.3% in 2030, with bullish sentiment.
The long-term forecast shows substantial upside, with the average price rising to $774.52 by 2050 and a ROI of 2349.4%, but these are estimates and not guarantees. Market conditions and other factors can affect actual results.
Yes. The 2030 max is $129.13, and the 2031 average is $110.83 with a max of $197.29, indicating that the $100 level is achievable within the forecast horizon.
Current price is $31.62 and the market cap is $539.05M.
RSI14 is 60.00, SMA50 is $26.96, SMA200 is $33.71, with a support level at $21.67 and resistance at $34.72. The 30-day price range is $22.45 to $44.54, and overall sentiment is bullish.
Claritev Corporation Community Discussion
0Share your Claritev Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.